Pulmonary surfactant augments cytotoxicity of silica nanoparticles: Studies on an in vitro air–blood barrier model

• Jennifer Y. Kasper,
• Lisa Feiden,
• Maria I. Hermanns,
• Christoph Bantz,
• Michael Maskos,
• Ronald E. Unger and
• C. James Kirkpatrick

Beilstein J. Nanotechnol. 2015, 6, 517–528, doi:10.3762/bjnano.6.54

• . Thus, a prior interaction of NPs with pulmonary surfactant components will occur. In the present study we explored the impact of pulmonary surfactant on the cytotoxic potential of amorphous silica nanoparticles (aSNPs) using in vitro mono- and complex coculture models of the air–blood barrier

• culture period. Keywords: air–blood barrier; cytotoxicity; inflammatory response; pulmonary surfactant; silica nanoparticles; Introduction Biological barriers of the human body which directly interface the external environment have, besides their actual physiological function, the vital task of

• protective alveolar surfactant lining layer (10–20 nm in thickness), that covers the entire alveolar surface [2]. It has already been shown that regardless of the NP surface properties they will be submerged in the aqueous phase of the alveolar lining layer after crossing the pulmonary surfactant layer [3][4

Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats

• Nadine Haberl,
• Stephanie Hirn,
• Alexander Wenk,
• Jörg Diendorf,
• Matthias Epple,
• Blair D. Johnston,
• Fritz Krombach,
• Wolfgang G. Kreyling and
• Carsten Schleh

Beilstein J. Nanotechnol. 2013, 4, 933–940, doi:10.3762/bjnano.4.105

• alveolar region [10][11][12]. Once deposited there, nanoparticles are found to interact with the epithelial lining fluid including pulmonary surfactant, lung macrophages and epithelial cells [13][14][15]. Depending on their physico-chemical properties, a small portion of the inhaled nanomaterials may even